MEN1, a known tumour suppressor gene associated with endocrine tumours [49], was one of the transcriptional regulators most strongly associated with negative TMRs, being the most enriched regulator for negative TMRs identified in both prostate tumour and prostate metastasis samples. This evidence concerns the gene MEN1 and neoplasm.